Can-Fite wins FDA orphan drug status for liver cancer drug

CF102 was found to be safe in preclinical and Phase I clinical trials. Healthcare

BiolineRX reports positive results in celiac trial

The preclinical trial on rodents found that BL-7010 was safe and reduces digestion of wheat gluten, thereby decreasing its toxicity. Healthcare

Accelmed in talks to buy US spinal therapy co
At a Landmark Ventures conference today, Dr. Uri Geiger spoke about the fund's investment policy, and relations with the FDA. Healthcare Teva tempers Laquinimod prognosis
"We believe it would be premature to file an NDA for Laquinimod at this time," the company said in its annual financial report. Healthcare Deutsche Bank more conservative on Teva than Merrill Lynch
Merrill Lynch and Deutsche Bank are both satisfied with Teva's financial report for the fourth quarter and full year of 2011. Healthcare Deutsche Bank more conservative on Teva than Merrill Lynch
Merrill Lynch and Deutsche Bank are both satisfied with Teva's financial report for the fourth quarter and full year of 2011. Healthcare Deutsche Bank more conservative on Teva than Merrill Lynch
Merrill Lynch and Deutsche Bank are both satisfied with Teva's financial report for the fourth quarter and full year of 2011. Healthcare Analysts upbeat on Teva results
Leader and Bank Hapoalim both reiterate "Outperform" recommendations for Teva after it published its financial report today. Healthcare Tiltan begins Phase II pancreatic cancer trial
TL-118 prevents blood flow to tumors, thereby preventing their growth, compared with chemotherapy. Healthcare “We can treat half world’s Gaucher patients”
Protalix CEO Dr. David Aviezer tells "Globes" that Uplyso is safer than its rival. Healthcare
Next Page »